{"altmetric_id":14166030,"citation":{"altmetric_jid":"clinicaltrialsgov","authors":["Alliance for Clinical Trials in Oncology"],"first_seen_on":"2016-11-29T20:34:46+00:00","handles":[],"isbns":[],"issns":[],"journal":"ClinicalTrials.gov","last_mentioned_on":1480452324,"links":["https:\/\/clinicaltrials.gov\/ct2\/show\/NCT02375204?term=Randomized+Phase+III+Trial+of+Initial+Salvage+Chemotherapy+for+Patients+with+Germ-Cell+Tumors&rank=1"],"nct_id":"NCT02375204","pubdate":"2015-02-20T00:00:00+00:00","publisher":"ClinicalTrials.gov","title":"Standard-Dose Combination Chemotherapy or High-Dose Combination Chemotherapy and Stem Cell Transplant in Treating Patients With Relapsed or Refractory Germ Cell Tumors","type":"clinical_trial_study_record"},"altmetric_score":{"score":7,"score_history":{"1y":7,"6m":0,"3m":0,"1m":0,"1w":0,"6d":0,"5d":0,"4d":0,"3d":0,"2d":0,"1d":0,"at":7},"context_for_score":{"all":{"total_number_of_other_articles":7822782,"mean":6.6331385505942,"rank":1080367,"this_scored_higher_than_pct":85,"this_scored_higher_than":6672300,"rank_type":"exact","sample_size":7822782,"percentile":85},"similar_age_3m":{"total_number_of_other_articles":250500,"mean":12.182767100866,"rank":51658,"this_scored_higher_than_pct":77,"this_scored_higher_than":195269,"rank_type":"exact","sample_size":250500,"percentile":77},"this_journal":{"total_number_of_other_articles":21271,"mean":10.123204701457,"rank":3457,"this_scored_higher_than_pct":75,"this_scored_higher_than":16031,"rank_type":"exact","sample_size":21271,"percentile":75},"similar_age_this_journal_3m":{"total_number_of_other_articles":751,"mean":10.082104,"rank":84,"this_scored_higher_than_pct":86,"this_scored_higher_than":649,"rank_type":"exact","sample_size":751,"percentile":86}}},"demographics":[],"counts":{"total":{"posts_count":1},"news":{"unique_users_count":1,"unique_users":["medscape"],"posts_count":1}},"posts":{"news":[{"title":"High-Dose Chemo Plus Stem Cells for Relapsed Metastatic Germ Cell Cancer","url":"http:\/\/ct.moreover.com\/?a=28765392285&p=1pl&v=1&x=ADRcAD1aHZJySpIIqBS4LA","license":"public","citation_ids":[14166030,18909244],"posted_on":"2016-11-29T20:45:24+00:00","summary":"NEW YORK (Reuters Health) - High-dose chemotherapy (HDCT) and autologous peripheral-blood stem-cell transplantation (PBSCT) may be able to cure men with relapsed metastatic testicular and other germ cell tumors, even when the approach is used as\u2026","author":{"name":"Medscape","url":"http:\/\/medscape.com\/","image":"https:\/\/s3.amazonaws.com\/weyland.altmetric.com\/news_sources\/logos\/000\/000\/055\/normal\/medscape.png?1369846939"}}]}}